Press & news

Monivent receives the first Neo100 order to Estonia through charity funding

3 Nov - 2022


Monivent has received an order of two Neo100 units and a year’s supply of disposables from Tartu University Children’s Hospital. This is the company’s first sales to Estonia and was made available through charity funding by Tartu University Hospital Children’s Foundation (SA Tartu Ülikooli Kliinikumi Lastefond).

With donations provided by individuals and companies, Tartu University Hospital Children’s Foundation support purchasing of new and necessary medical equipment for the Children’s Clinic of the Tartu University Hospital and other hospitals around Estonia. With financial support from the charity organization, Tartu University Children’s Hospital has now been able to purchase two Neo100 systems, which will be the first systems Monivent deliver to Estonia.

”Tartu University Hospital Children’s Foundation is delighted that with the help of our wonderful donators and in cooperation with Monivent AB we can purchase new ventilation units for monitoring the health conditions of the smallest patients of the Children’s Clinic, which the doctors have also eagerly been waiting for”, says Eveli Ilves, Support Manager and Member of Managing Board at Tartu University Hospital Children’s Foundation.

“It is very satisfying that we now are to deliver the first Neo100 systems to Estonia and even more rewarding that it happens through the support of the charity organization Tartu University Hospital Children’s Foundation. This charity organization is doing a heartwarming work for sick children in Estonia, and it feels very good that with their financial support Neo100 will be used to improve the care for newborns”, says Karin Dahllöf, CEO of Monivent.

For more information, please contact:
Karin Dahllöf, CEO
Phone: +46 70 748 01 30

Monivent AB (”Monivent”) develops, manufactures and sells medical devices in order to improve the emergency care provided to newborns in need of respiratory support at birth. About three to six percent of all newborns end up in this critical situation and healthcare professionals today lack good tools to determine how effective this manual ventilation is. Monivent has developed equipment that measure the airflow to the child directly in the face mask via a sensor module that sends data wirelessly to an external monitor. The caregiver thereby receives immediate feedback, which enables necessary adjustments to support an effective but at the same time gentle treatment. The company is also marketing a product for simulation-based training on manikins, building on the same technology as the clinical product. The clinical product, Monivent Neo100, is not available for sale in the United States.

Tartu University Hospital Children’s Foundation was founded in 2000 by 26 individuals. Tartu University Hospital Children’s Foundation is one of Estonia’s oldest and largest charitable foundations and they support hundreds of children in need of special treatment and care, and their families. They also support the purchasing of medical equipment to hospitals. In their 19 years of operating, they have collected more than 8 million Euros through donation, to improve the quality of treatment of the children.

Bilaga: 2022-11-3 Monivent receives the first Neo100 order to Estonia through charity funding

Kommande händelser och rapporter

26 augusti 2024

Q2-rapport 2024

18 november 2024

Q3-rapport 2024